TGFB1 and hepatocellular carcinoma: Based on in-depth research on the mechanism of the TGF-β/SMAD pathway in HCC, targeted strategies against TGF-β/SMAD have been developed, such as chemotherapy drugs, small molecule inhibitors, therapeutic vaccines, traditional Chinese medicine formulations.